NCT04928612View on ClinicalTrials.gov

A Study of CBP-1018 in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Solid Tumor
Interventions
DRUG

CBP-1018

CBP-1018 for injection, IV infusion

Trial Locations (2)

300060

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

510288

NOT_YET_RECRUITING

Sun Yat-Sen memorial hospital, Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Coherent Biopharma (Suzhou) Co., Ltd.

INDUSTRY

NCT04928612 - A Study of CBP-1018 in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter